FDA approves first drug-coated balloon; Delivery biz PolyPid files IPO;

> C.R. Bard's ($BCR) Lutonix 035 Drug Coated Balloon Catheter became the first drug-coated balloon to receive PMA approval from the FDA on Oct. 10. It is indicated for the reopening of narrowed or blocked arteries in the knee or thigh in patients with peripheral artery disease (PAD). Story

> PolyPid, developer of a clinical-stage antibiotic coating for bone repair, just filed for a $24 million IPO with the Securities and Exchange Commission. Story

Suggested Articles

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.